• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMÉRIEUX ITALIA S.P.A. VIDAS® 3

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMÉRIEUX ITALIA S.P.A. VIDAS® 3 Back to Search Results
Catalog Number 412590
Medical Device Problem Codes Pumping Problem (3016); Appropriate Device Problem Term/Code Not Available (3191)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Malfunction
Event or Problem Description
Product description.The vidas® 3 system is a complete standalone immunodiagnostic system intended for trained and qualified laboratory technicians (daily routine use) and laboratory administrators (application configuration).The vidas® 3 system is intended to be used with vidas® reagents in clinical laboratories only.This device is an in vitro diagnostic medical device for professional use only.Issue description on 10-nov-2023, a customer in france notified biomérieux of potential false positive patient results when using compartment d of vidas® 3 system reference (b)(4) (serial number (b)(6).This customer noticed that the results for position d1 were not identical with the other positions (this started with the c2 hiv control).Customer results: c2 hiv : 0.42 (positive) - 101 rfv - automatic - d1.0.09 (negative) - 22 rfv - manual - c1.Hiv patient : 0.48 (positive) - 115 rfv - automatic - d1.0.08 (negative) - 21 rfv - automatic - a1.Patient for vcam : 0.46 (positive) - 366 rfv - automatic - d1.0.06 (negative) - 50 rfv - manual - b1.The instrument logs analysis concluded that there was no problem identified.At the time of this assessment, there was no indication of patient harm, incorrect treatment, or delay.The wrong results have not been given to the physician.A biomérieux investigation will be initiated.
 
Additional Manufacturer Narrative
An internal investigation was performed following a notification from a customer of false positive patient results when using compartment d of vidas® 3 system reference 412590 (serial number (b)(6)).1.Immediate actions done.Disconnect the section d.The wrong results have not been given to the physician.Data collection for investigation.The local customer service (lcs) investigated directly on site and decided to replace the pump of instrument section d.2.Investigation the investigation was performed based on the information communicated by the customer and the biomérieux field service engineer (fse).The instrument log files were reviewed, but there was no possibility to investigate directly on the instrument as the the pump that was replaced was not retained.2.1 investigation on site by the fse: the fse observed an issue on section d, the qualification test called functional and operational test (fot) was failed.Based on the test performed, it was decided to replace the pump of section d.This action solved the issue (fot result is passed.) 2.2 instrument logs analysis: this analysis shows that there is no issue on the instrument regarding: the temperatures of the sections; the pipettor; the scanner head; the section pump.Specifically, on the three (3) false-positive results reported, there was no difference compared to a typical analysis.A complaint analysis did not reveal this issue as a systemic quality issue.3.Conclusion the actions taken by the fse (replaced pump) solved the issue at the customer site.Despite all the actions performed during our investigation, biomérieux was not able to find the root cause of the complained issue.There was no possibility to test the pump in its original conditions and no other pump defect was identified.A retrospective analysis performed by the customer confirmed that no other result was impacted by the problem; the samples with false-positive results were successfully rerun on a different instrument section, therefore excluding any patient impact.As a result of the investigation, there is no reconsideration of the performance of vidas® 3 system reference (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® 3
Common Device Name
VIDAS® 3
Manufacturer (Section D)
BIOMÉRIEUX ITALIA S.P.A.
via di campigliano 58 / loc. p
firenze 50012
IT  50012
Manufacturer (Section G)
BIOMERIEUX ITALIA S.P.A.
via di campigliano 58 / loc. p
firenze 50012
IT   50012
Manufacturer Contact
matt floretta
595 anglum road
hazelwood, MO 63042
MDR Report Key18235738
Report Number9615037-2023-00015
Device Sequence Number7160019
Product Code JJE
UDI-Device Identifier03573026380175
UDI-Public03573026380175
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K141133
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number412590
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/10/2023
Supplement Date Received by Manufacturer01/15/2024
Initial Report FDA Received Date11/30/2023
Supplement Report FDA Received Date01/19/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device A
Patient Sequence Number1
Patient SexUnknown
-
-